Kestra Medical Technologies(KMTS)
Focus: Kestra Medical Technologies is a publicly traded medical device company specializing in wearable cardiac devices, with a focus on sudden cardiac arrest prevention and management. The company generated $60M in revenue (FY 2026) with significant R&D investment in next-generation defibrillation technologies.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
115-25 this month
Contracting — net -25 jobs in 30d
64 added, 89 removed. Active reduction in progress.
Should You Work at Kestra Medical Technologies?
AI assessmentStrong growth and financing story with solid clinical focus, but high burn rate and supply-chain-heavy hiring suggest execution risk; best for professionals comfortable with medical device scaling environments and willing to weather pre-profitability volatility.
Why Work Here
- Strong revenue growth trajectory: revenue doubled from $28M (FY 2025) to $60M (FY 2026), signaling scaling operations and hiring momentum.
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$60M
Pipeline & Clinical Trials
Defibrillation
Sudden Cardiac ArrestClinical Trials (1)
NCT05135403ASSURE WCD Clinical Evaluation - Post Approval Study (ACE-PAS)
N/AHelp build intelligence for Kestra Medical Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.